NOVOS

📍 NEW YORK, United States🗓 Founded 2018👥 28 employees💰 Last funded Jul 2021
NOVOS leverages science and data to create the best nutraceuticals to extend human lifespan. We at NOVOS believe much more can be done to slow down aging through science, so we create the first supplements in the world that are: • Based on the best available science • Created with the world’s top experts in the aging field • Use scientifically validated ingredients that extend lifespan in various organisms • Focused on the 12 mechanisms of aging mechanisms to leverage synergistic effects • Include ingredients shown to have beneficial effects on aging in humans The result is NOVOS, the best longevity supplements available. NOVOS’ scientific advisors are biochemists, geneticists and professors from Harvard, MIT, University of Liverpool, University of Washington, Salk Institute, and other universities & institutes around the world. Our scientists have received honors that include Breakthroughs in Gerontology Award, an Alzheimer’s Association New Investigator Award, and an Ellison Medical Foundation New Scholar in Aging Award. Each one of them is a pioneer in the longevity field and have been featured by 60 Minutes, TIME magazine, BBC, CNN, Science, Scientific American, Washington Post, New York Times, and countless other publications. NOVOS is a Public Benefit Corporation (PBC). A portion of our profits and equity is donated to nonprofits in the longevity science space, like the 501(c)(3), Life Extension Advocacy Foundation (LEAF). NOVOS also creates free content to educate people on how to live longer, healthier lives, even if they don’t use NOVOS, which you can find on our blog at NovosLabs.com.
4
Total investors
2
Early stage
2
Mid stage
0
Late stage
2018
Founded
Investor geography4 countries
Singapore
1
China
1
United States
1
Germany
1
Investor activity2018–2021 · investors recorded per year
201812020120212
Recent (last 2y)Earlier
Frequently asked questions
Who invested in NOVOS?
NOVOS has 4 investors on record on gritt.io, including 2 early-stage backers, 2 mid-stage.
When did NOVOS last raise funding?
The most recent investment in NOVOS recorded on gritt.io was in July 2021.
When was NOVOS founded?
NOVOS was founded in 2018.
What industry is NOVOS in?
NOVOS operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is NOVOS based?
NOVOS is headquartered in NEW YORK, United States.